Can Quantitative MRI After cTACE Help Predict Survival ?

Completed

Conditions studied: Hepatocellular Carcinoma (HCC)

In brief

Transcatheter arterial chemoembolization (TACE) is a widely accepted palliative therapy for the treatment of HCC. Palliative means that it does not cure the disease prolongs your life and improves quality of life. During TACE, a mixture of chemotherapy drugs is combined with an oil called lipiodol. Lipiodol has a role as both drug carrier and embolic agent (a material that blocks blood flow to tumors). The lipiodol/chemotherapy mixture is injected into an artery (blood vessel) directly supplying blood to a HCC tumor. Lipiodol is made up of fat and water which can be seen on MRI. Therefore, MRI can be used to quantify the amount of lipiodol delivered to the HCC tumors. In this study, the investigators want to see if patient survival is related to the amount of lipiodol delivered to HCC tumors.

Key facts

Study ID

NCT02173119

Run by

Medical College of Wisconsin

People needed

23

Starts

2014-08-01

Expected to finish

2018-03-07

Last updated by the study team

2019-06-10

Who can join

Age: 18 and older, up to 89. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Prospective studies will be performed in 20 patients with Hepatocellular Carcinoma (HCC) independently scheduled to undergo TACE; tumors in each of these candidates will already have been deemed un-resectable.
• Reasons may include
• concurrent co-morbidities including cardiac or respiratory compromise
• recurrent or multi-lobar disease
• cirrhosis or portal hypertension
• vascular invasion
• high tumor burden
• contraindications to general anesthesia.
• Diagnosis of HCC will have been established by a) biopsy or b) non-invasively, based upon > 2cm diameter tumor with characteristic imaging findings in the setting of cirrhosis.
• Male or female aged 18 to 89 years, all ethnicities

You may not qualify if…

• Infiltrative or diffuse HCC.
• Does not meet inclusion criteria.
• Pregnant women.
• Individuals with pacemakers or other non-MRI compatible metallic implants.
• Hemodialysis patients or patients with severely impaired renal function.
• Individuals with severe claustrophobia or unwilling to get a MRI.

Where it is running

• Medical College of Wisconsin/Froedtert Memorial Lutheran Hospital — Milwaukee, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.